Status:

COMPLETED

Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28)

Lead Sponsor:

Rigshospitalet, Denmark

Collaborating Sponsors:

Octapharma

Conditions:

Aortic Aneurysm, Thoracic

Endothelial Dysfunction

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Effects of OctaplasLG® on endothelial integrity in patients undergoing emergency surgery for thoracic aortic dissections - a randomized, controlled, single-blinded investigator-initiated pilot trial

Detailed Description

Trial Name: VIPER-OCTA trial - Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas trial Background * Patients operated for thoracic aortic dissections in deep hypothermic circulatory a...

Eligibility Criteria

Inclusion

  • Patient eligible for emergency surgery on cardiopulmonary bypass pump for a thoracic aortic dissections AND
  • Age \> 18 years AND
  • Consent obtainable from patient or by proxy (independent physicians and/or next of kin)

Exclusion

  • Documented refusal of blood transfusion OR
  • FFP transfusion before randomization OR
  • Aortic dissection due to trauma OR
  • Treatment with GPIIb/IIIa inhibitors \< 24h from screening OR
  • Withdrawal from active therapy OR
  • Expected to die \< 24h OR
  • Previously within 30 days included in a randomized trial, if known at the time of enrolment
  • Known IgA deficiency with documented antibodies against IgA
  • Known hypersensitivity to OctaplasLG®: the active substance, any of the excipients (Sodium citrate dihydrate, Sodium dihydrogenphosphate dihydrate or Glycine) or residues from the manufacturing process (Tri (N-Butyl) Phosphate (TNBP) and Octoxynol (Triton X-100))
  • Known severe deficiencies of protein S
  • Pregnancy (non-pregnancy confirmed by patient being postmenopausal or having a negative serum-hCG)

Key Trial Info

Start Date :

November 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2016

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT02253082

Start Date

November 1 2014

End Date

December 1 2016

Last Update

December 20 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rigshospitalet, Copenhagen University Hospital

Copenhagen, Denmark, DK-2100